Clinical Supply Regulatory Articles

1. Global Labeling And Packaging In Complex Supply Environments 6/18/2026

   Global labeling and packaging are central to clinical supply performance, shaping regulatory compliance, serialization, and design choices that affect patient safety now.

2. What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release 6/15/2026

   Batch release delays rarely start in QA. Learn how CQV, digital integrity, risk-based validation, and global compliance keep clinical supplies moving.

3. How The Iran Conflict Threatens Global Clinical Supply Chains 6/9/2026

   Geopolitical disruption is exposing hidden weaknesses in clinical supply networks, forcing sponsors to rethink inventory, depots, comparators, and trial continuity.

4. Unlocking The Value Of Real-World Data In Global Clinical Trials 6/5/2026

   Global real-world data can accelerate trials or quietly distort forecasts, inventory strategy, and regulatory decisions across clinical supply operations.

5. Want Faster FDA Release For Pharmaceutical Imports? Here's How. 5/28/2026

   FDA import delays can derail clinical trials. Learn the exact data, documentation, and compliance steps that speed pharmaceutical release.

6. Inside GCSG 2026: Clinical Supply Impact On Patient Experience 5/21/2026

   This GCSG 2026 event recap with Steve Jacobs (including video) highlights how clinical testing and supply decisions shape patient experience, among other buzzy topics.

7. U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership 5/21/2026

   China's clinical trial system now outpaces the U.S., exposing regulatory delays that ripple into supply planning, manufacturing windows, and drug development speed. 

8. From Individual Shipments To Patterns: How Compliance Is Understood Over Time 5/13/2026

   Compliance shifts from single shipments to patterns over time. Consistency in identity, documentation, and rationale reveals structure that makes decisions traceable.

9. At The Point Of Review: How Clinical Shipments Are Evaluated In Practice 5/6/2026

   At review, clinical shipments become a single consolidated record. Delays arise when relationships between product identity, classification, and documentation are unclear.

10. The cGMP Reality Of Clinical Supply For Advanced Therapies 5/5/2026

    Breakthrough therapies fail without cGMP‑ready supply. In cell and gene therapies, quality systems, timing, documentation and logistics dictate patient access.